Alliance Boots appoints Horlacher as new Asia director
This article was originally published in Scrip
The UK group Alliance Boots has appointed Fritz Horlacher as the regional director for Asia of its healthcare division. Elaine Cheung has been appointed as the regional chief financial officer for the division, reporting to Mr Horlacher, who retired as CEO of the private Hong Kong-based Asian pharmaceutical distribution group Zuellig Pharma in 2008.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Plus deals involving Takeda/OrigiMed, Amcure/Hinova, AUM/Newsoara, Taiho/Lung Therapeutics, 3D Medicines/Aravive, HitGen/Baiyunshan, Dong-A/Jiangsu Hengrui, and Crescita/Juyou.
Tislelizumab meets overall survival endpoint in later-line NSCLC at planned interim analysis, but faces exploding competition in the Chinese immuno-oncology sector.